Lymphoma in Cardiac Transplant Recipients Associated with Cyclosporin A, Prednisone and Anti-Thymocyte Globulin (ATG)
Cardiac transplantation has been used since 1968 to restore cardiac function in selected patients with otherwise unmanageable heart disease. In these recipients successful outcome of the procedure has been highly dependent upon effective management of allograft rejection using immunosuppressive agents. Prior to 1980 these agents included Azathioprine, corticosteroids and antithymocyte globulin — ATG (conventional therapy). In 1980 cyclosporin A, a fungal product whose therapeutic effect appears to result from its ability to block allograft directed T cell cytotoxic responses while leaving intact T cell suppressoV responses, was substituted for azathioprine in the conventional therapy regimen (cyclosporin A therapy) (1,2). Although outcome of transplantation has been favorably effected in patients treated with cyclosporin A (79% one year survival vs. 63% in conventionally treated recipients) morbidity due to lymphoma has increased.
KeywordsAntithymocyte Globulin Viral Capsid Antigen Cardiac Transplant Recipient Diffuse Large Cell Lymphoma Splenic Artery Aneurysm
Unable to display preview. Download preview PDF.
- 1.Oyer, P.E., Stinson, E.B., Jamieson, S.W., Hunt, S.A., Billingham, M., Scott, W., Bieber, C.P, Reitz, B.A., and Humway, N.E. Cyclosporin A in cardiac allografting: a preliminary experience. Transpl. Proc., in press.Google Scholar
- 3.Bieber, C.P., Hunt, S.A., Schwinn, D.A., Jamieson, S.W., Reitz, B.A., Oyer, P.E., Shumway, N.E., and Stinson, E.B. Complications in long-term survivors of cardiac transplantation. Transpl. Proc, 13:207, 1981.Google Scholar
- 4.Pennock, J.L., Oyer, P.E., Reitz, B.A., Jamieson, S.W., Bieber, C.P., Wallwork, J., Stinson, E.B., and Shumway, N.E. Cardiac transplantation in prospective for the future. J. Thorac. and Cardio. Surg., 83:168, 1982.Google Scholar
- 9.Saemundsen, A.K., Purtilo, D.T., Sakamoto, K., Sullivan, J.L., Synnerholm, A.C., Hanto, D.W., Simmons, R.L., Anvret, M., Collins, R., and Klein, G. Documentation of EB virus infections in immunodeficient patients with life-threatening lymphoproliferative diseases by EB virus complementary RNA/DNA and viral DNA/DNA hybridization. Cancer Res., 41:4237, 1981.PubMedGoogle Scholar
- 10.Bieber, C.P., Pennock, J.L., and Reitz, B.A. Lymphoma in Cyclosporin A treated non human primate allograft recipients in malignant lymphomas. In: H.S. Kaplan and S. Rosenberg, p. 219. New York: Academic Press, 1982.Google Scholar
- 11.Heberling, R.L., Bieber, C.P., and Kalter, S.S. Establishment of a lymphoblastoid cell line from a lymphoraatous Cynomolgus monkey. In: D.S. Yohn and J.R. Blakeslee (eds.), Advances in Comparative Leukemia Research. pp. 385–386. Amsterdam: Elsevier Biomedical, 1982.Google Scholar
- 16.Prieksaiks, J. — Personal communication.Google Scholar